Cervical Cancer
Pembrolizumab plus chemoradiotherapy was shown to improve survival in advanced cervical cancer.
Pembrolizumab use is increasing among patients with recurrent cervical cancer.
Camrelizumab plus apatinib demonstrates robust and sustained efficacy in treating patients with advanced cervical cancer.
LSU LCMC Health Cancer Center has been awarded a $1.5 million grant to help combat barriers to cervical cancer prevention.
Each year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this ...
The COVID-19 pandemic was a associated with a large, but temporary decline in breast cancer screening, cervical cancer ...
It's no secret that the human papillomavirus (HPV) virus causes cancer - in fact it's linked to more than 90% of ...
Although screening for cancer is a helpful strategy for early detection, overscreening can also be a problem. Risks ...
Advertisement
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.